Paget’s disease

Paget’s disease is a chronic disorder that can affect bone remodeling or the skin, leading to structural changes and clinical symptoms. It is important to distinguish between Paget’s disease of bone and mammary or extramammary Paget’s disease due to differences in etiology, pathology, and management.

Definition and Classification

Definition of Paget’s Disease

Paget’s disease refers to a group of disorders characterized by abnormal cellular activity affecting either bone tissue or epidermal structures. In bone, it involves excessive bone resorption followed by disorganized bone formation. In the breast and other skin regions, it involves malignant epithelial cells infiltrating the epidermis.

Types of Paget’s Disease

• Paget’s Disease of Bone (Osteitis Deformans): A metabolic bone disorder leading to enlarged and weakened bones due to abnormal remodeling.
• Paget’s Disease of the Breast (Mammary Paget’s Disease): A rare malignancy presenting with eczematous changes of the nipple and areola, often associated with underlying carcinoma.
• Extramammary Paget’s Disease: Malignant lesions of the epidermis occurring in areas rich in apocrine glands, such as the genital and perianal regions.

Etiology and Pathogenesis

Genetic Factors

Genetic predisposition plays a role in Paget’s disease of bone, with mutations in genes related to osteoclast regulation increasing susceptibility. Familial clustering has been observed in multiple populations.

Environmental Factors

Environmental triggers such as viral infections and other unknown factors may contribute to the development of Paget’s disease of bone, though evidence is variable. Lifestyle and exposure history may influence disease expression in susceptible individuals.

Pathophysiology of Bone Involvement

• Abnormal Osteoclast Activity: Increased osteoclastic bone resorption disrupts normal bone architecture.
• Disorganized Bone Remodeling: Excessive and irregular bone formation results in structurally weak, enlarged, and deformed bones.

Pathophysiology of Mammary and Extramammary Disease

• Malignant Cell Infiltration: Paget cells infiltrate the epidermis causing eczematous changes and ulceration.
• Association with Underlying Carcinoma: Mammary Paget’s disease is commonly associated with ductal carcinoma in situ or invasive breast cancer. Extramammary lesions may be associated with internal malignancies.

Clinical Features

Symptoms of Paget’s Disease of Bone

• Bone Pain: Persistent or intermittent pain localized to affected bones, often worse at night or with activity.
• Bone Deformities: Enlarged, bowed, or misshapen bones, commonly affecting the skull, pelvis, spine, and long bones.
• Fractures: Increased susceptibility to pathological fractures due to weakened bone structure.
• Hearing Loss: Conductive or sensorineural hearing impairment when the skull or temporal bone is involved.

Symptoms of Mammary Paget’s Disease

• Nipple Eczema or Erosion: Redness, flaking, or ulceration of the nipple and areola.
• Itching or Burning Sensation: Local discomfort or tenderness in the affected area.
• Underlying Breast Mass: Palpable lump or mass may indicate associated ductal carcinoma.

Symptoms of Extramammary Paget’s Disease

• Red, Scaly, or Itchy Lesions: Chronic eczematous patches on the vulva, scrotum, perianal region, or axillae.
• Predilection for Genital or Perianal Areas: Lesions typically occur in areas with high density of apocrine glands.

Diagnostic Evaluation

Laboratory Tests

• Serum Alkaline Phosphatase: Elevated levels indicate increased bone turnover in Paget’s disease of bone.
• Calcium and Phosphate Levels: Usually normal but may be evaluated to exclude metabolic bone disorders.

Imaging Studies

• Bone Scintigraphy: Sensitive for detecting areas of increased bone activity in Paget’s disease of bone.
• X-rays of Affected Bones: Identify cortical thickening, bone enlargement, and structural deformities.
• MRI or CT: Used to assess local complications such as fractures, spinal cord compression, or soft tissue involvement.

Histopathology

• Biopsy of Bone Lesions: Confirms abnormal osteoclast and osteoblast activity in Paget’s disease of bone.
• Skin Biopsy for Mammary or Extramammary Lesions: Identifies Paget cells and evaluates for associated carcinoma.

Management and Treatment

Paget’s Disease of Bone

• Bisphosphonates: First-line therapy to inhibit osteoclast activity and reduce bone turnover.
• Calcitonin Therapy: Alternative treatment for patients intolerant to bisphosphonates, helping to regulate bone remodeling.
• Pain Management: Analgesics such as acetaminophen or NSAIDs to relieve bone pain.
• Surgical Intervention: Used for fracture repair, joint replacement, or correction of severe deformities.

Mammary and Extramammary Paget’s Disease

• Surgical Excision: Wide local excision or mastectomy depending on the extent and presence of underlying carcinoma.
• Radiotherapy: Considered in patients who are not surgical candidates or for adjuvant treatment.
• Topical or Systemic Chemotherapy: Employed in select cases with invasive or recurrent disease.

Complications

• Bone Fractures: Pathological fractures due to weakened and deformed bone structure.
• Osteoarthritis: Secondary joint degeneration in areas affected by abnormal bone growth.
• Malignant Transformation: Rarely, Paget’s disease of bone can progress to osteosarcoma.
• Metastasis: Mammary and extramammary Paget’s disease can spread to regional lymph nodes or distant organs if underlying carcinoma is present.

Prognosis

The prognosis of Paget’s disease varies depending on the type, severity, and timely management. Patients with Paget’s disease of bone who receive appropriate therapy often experience symptom relief and reduced risk of complications. Mammary and extramammary Paget’s disease prognosis largely depends on early detection and the presence or absence of underlying carcinoma. Delayed diagnosis or invasive malignancy can adversely affect outcomes.

Prevention and Screening

• Genetic Counseling: Recommended for familial cases of Paget’s disease of bone to inform at-risk individuals.
• Early Detection Through Imaging: Routine X-rays or bone scans in symptomatic individuals to identify disease before complications arise.
• Monitoring of Biochemical Markers: Regular measurement of serum alkaline phosphatase to detect increased bone turnover.
• Regular Breast Examination: Clinical and imaging surveillance for early detection of mammary Paget’s disease.

References

1. Roodman GD. Paget’s disease of bone. N Engl J Med. 1997;336(7):558-565.
2. Seeman E. Paget’s disease of bone. N Engl J Med. 2006;355(12):1262-1270.
3. Bellah R, Pant S. Paget’s disease of bone: pathophysiology and clinical management. Curr Osteoporos Rep. 2019;17(3):123-131.
4. Fitzpatrick TB, Johnson RA, Wolff K, et al. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw-Hill; 2019.
5. Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. Philadelphia: Elsevier; 2018.
6. Hughes LE, Mansel RE, Webster DJ. Paget’s disease of the breast: clinical features and management. Br J Surg. 1986;73(5):375-378.
7. Kang S, Amagai M, Bruckner AL, et al. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill; 2020.
8. Ralston SH, Albagha OM. Epidemiology and genetics of Paget’s disease of bone. Bone. 2014;63:2-12.
9. Fukunaga M, Sasaki T. Extramammary Paget’s disease: clinical features and treatment. J Dermatol. 2017;44(1):1-9.